The importance of the liver in mediating the anti-obesity action of glucagon administration is exemplified by findings in liver-specific knockout models, where the absence of the GCGR ablates the ability of glucagon to induce weight loss (54, 81). This evidence concerns the gene GCGR and obesity due to melanocortin 4 receptor deficiency.